88 related articles for article (PubMed ID: 32940815)
21. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
[TBL] [Abstract][Full Text] [Related]
22. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
23. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
24. Simple HPLC-UV method for determination of iohexol, iothalamate, p-aminohippuric acid and n-acetyl-p-aminohippuric acid in human plasma and urine with ERPF, GFR and ERPF/GFR ratio determination using colorimetric analysis.
Farthing D; Sica DA; Fakhry I; Larus T; Ghosh S; Farthing C; Vranian M; Gehr T
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):267-72. PubMed ID: 16169291
[TBL] [Abstract][Full Text] [Related]
25. The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer.
Shingyoji M; Iizasa T; Higashiyama M; Imamura F; Saruki N; Imaizumi A; Yamamoto H; Daimon T; Tochikubo O; Mitsushima T; Yamakado M; Kimura H
BMC Cancer; 2013 Feb; 13():77. PubMed ID: 23409863
[TBL] [Abstract][Full Text] [Related]
26. Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors.
Zhang C; Leng W; Sun C; Lu T; Chen Z; Men X; Wang Y; Wang G; Zhen B; Qin J
EBioMedicine; 2018 Apr; 30():120-128. PubMed ID: 29576497
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous determination of p-aminobenzoic acid and its metabolites in the urine of volunteers, treated with p-aminobenzoic acid sunscreen formulation.
Wang LH; Huang WS; Tai HM
J Pharm Biomed Anal; 2007 Mar; 43(4):1430-6. PubMed ID: 17118613
[TBL] [Abstract][Full Text] [Related]
28. Urinary protein biomarkers in the early detection of lung cancer.
Nolen BM; Lomakin A; Marrangoni A; Velikokhatnaya L; Prosser D; Lokshin AE
Cancer Prev Res (Phila); 2015 Feb; 8(2):111-9. PubMed ID: 25416410
[TBL] [Abstract][Full Text] [Related]
29. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
30. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
31. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
32. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
33. Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
J Breath Res; 2016 Mar; 10(2):026002. PubMed ID: 27007686
[TBL] [Abstract][Full Text] [Related]
34. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study.
Takamori S; Ishikawa S; Suzuki J; Oizumi H; Uchida T; Ueda S; Edamatsu K; Iino M; Sugimoto M
Thorac Cancer; 2022 Feb; 13(3):460-465. PubMed ID: 34918488
[TBL] [Abstract][Full Text] [Related]
36. Multiplexed Serum Biomarkers for the Detection of Lung Cancer.
Ma S; Wang W; Xia B; Zhang S; Yuan H; Jiang H; Meng W; Zheng X; Wang X
EBioMedicine; 2016 Sep; 11():210-218. PubMed ID: 27575387
[TBL] [Abstract][Full Text] [Related]
37. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
39. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a serological molecular model for the early diagnosis and progression monitoring of bone metastasis in lung cancer.
Teng X; Wei L; Han L; Min D; Du Y
BMC Cancer; 2020 Jun; 20(1):562. PubMed ID: 32546271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
